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Abstract
Aim: The early-onset intrauterine growth restriction (IUGR) is associated with severe placental insufﬁciency
and Doppler abnormalities. The late-onset IUGR is associated with mild placental insufﬁciency and normal
Doppler velocimetry. The computerized cardiotocographic (cCTG) monitoring is used to evaluate the fetal
well-being in pregnancies complicated by IUGR. Our aim was to investigate the cardiotocographic character-
istics of IUGR fetuses and to identify every cCTG difference between Healthy and IUGR fetuses.
Methods: Four hundred thirty pregnant women were enrolled starting from the 28th week of gestation until
the time of delivery: 200 healthy and 230 IUGR fetuses. Fetal heart rate (FHR) baseline (FHR), short-term
variability (STV), long-term irregularity (LTI), delta, interval index (II), approximate entropy (ApEn), high
frequency (HF), low frequency (LF), movement frequency (MF), LF/(HF + MF) ratio (LF/(HF + MF)) and
number of decelerations were examined. Newborn baby data were also collected.
Results: The parameters of short- and medium-term variability discriminate between IUGR and healthy
fetuses before 36 weeks including FHR, STV, LTI and delta discriminate between each subgroup of IUGR
were compared to each one of the other two (P < 0.05).
Conclusion: cCTG is a useful tool for the evaluation of chronic hypoxemia, which causes a delay in the mat-
uration of all components of the autonomic and central nervous system. However, cCTG requires integration
with fetal ultrasound and Doppler vessels evaluation to improve the ability to predict the neonatal outcome.
Key words: antepartum fetal monitoring, computerized cardiotocography, early-onset growth restriction,
fetal heart rate, late-onset growth restriction.
Introduction
The term IUGR (intrauterine growth restriction) is
used to deﬁne a fetus with estimated fetal weight
<10th centile for the gestational age and it is not able
to reach its genetically determined growth potential
for many factors. To date, the deﬁnition of IUGR
remains elusive and the best way to identify IUGR is
yet to be determined.1 IUGR complicated 3–9% of all
pregnancies with 30% of stillborn infants cases.2,3 In
addition, IUGR is associated with a four- to eightfold
higher perinatal mortality and a series of neonatal
complications (persistent pulmonary hypertension,
polycythemia, hypothermia, hypoglycemia, hypergly-
cemia, pulmonary hemorrhage, premature delivery,
asphyxia intrapartum).2–7
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According to the time of onset of growth restriction
we distinguished the early-onset from the late-onset
IUGR. The early-onset (<32–34 weeks) represents
20–30% of all IUGRs and it is associated with severe
placental insufﬁciency, Doppler abnormalities and
preeclampsia (50% of cases).7 According to some
studies, the pathophysiology of early-onset is a reduc-
tion of more than 30% in the vascular area of the cho-
rionic villi, resulting in severe placental insufﬁciency
and chronic fetal hypoxia.8–10
The late-onset IUGR represent the 70–80% of IUGR
cases, it is frequently associated with mild placental
insufﬁciency and normal Doppler velocimetry. The
pathophysiology of the late-onset is the insufﬁcient
maturation of the chorionic villi or the reduction of
their area in the placenta.9
The electronic fetal heart rate (FHR) monitoring is
one of the most widespread but not an invasive
method to evaluate the fetal well-being during the
antenatal period, especially in pregnancies compli-
cated by IUGR.
Many efforts have been made to understand the
mechanisms of regulation of FHR variability in Healthy
and IUGR fetuses. Computerized cardiotocography
(cCTG) provide a standardized method to evaluate con-
ventional CTG parameters and introduced quantitative
measures of linear and nonlinear indices related to FHR
variability as a multiparametric analysis of fetal cardio-
vascular and nervous activity. The presence of signiﬁ-
cant beat to beat variation suggests intact baroreﬂex,
sympathetic/parasympathetic tone and central control
indicating normal central nervous system (CNS) respon-
siveness and normal local CNS metabolic environment
reﬂecting fetal health.10–12
Our aim was to evaluate the trend of cCTG param-
eters in IUGR fetuses and to identify every cCTG dif-
ference between Healthy and IUGR fetuses.13
Materials and Methods
This retrospective study was carried out at the
Department of Obstetrical-Gynecological and Urologi-
cal Science and Reproductive Medicine of the
Federico II University (Italy) in a period of 3 years
(2015–2017). All pregnant women gave their written
informed consent. Starting from a population of 5400
pregnant women 430 pregnant women composed of
200 Healthy and 230 IUGR fetuses fulﬁlled the criteria
of the study. Inclusion criteria were Caucasian ethnic-
ity; singleton pregnancy; certain pregnancy dating;
cCTGs with a signal loss of less than 15% over the
whole record. cCTG monitoring was recorded once a
week for IUGR and Healthy fetuses but only the last
cCTG record within 24 h of delivery was considered
and the delivery indication was only for fetal condi-
tion in IUGR group. We considered as ‘Healthy’ a
fetus whose growth is appropriate for gestational age
without any chromosomal and major congenital
anomalies. Healthy fetuses were subjected to cCTG
monitoring at the same gestational weeks of IUGR
ones as admission test in hospital for preterm contrac-
tions without preterm premature rapture of mem-
branes or vaginal swab positive for infections before
labor. Newborn baby data (sex, weight, Apgar score,
access to neonatal intensive care, umbilical artery pH
and gas values) were collected.
We excluded preexisting maternal disease, drug abuse,
fetuses with chromosomal and major congenital anoma-
lies, and inadequate umbilical cord samples at birth.
The pregnant women were enrolled starting from the
28th week of gestation until the time of delivery. Gesta-
tional age was accurately calculated from the ﬁrst day of
the last menstrual period and conﬁrmed by ultrasound
measurement of the embryo or fetus in the ﬁrst trimes-
ter, according to the population nomograms.14 The diag-
nosis of IUGR was based on the evaluation of estimated
weight and estimated abdominal circumference below
the 10th centile, according to the gestational age. In the
early-onset IUGR the diagnosis was also based on the
Doppler criteria (pulsatility index [PI] of UA >95th
centile for the gestational age irrespective of the presence
or absent of reversed end-diastolic ﬂow).8
To discriminate between early- and late-onset
IUGR, the study population was divided into three
subgroups according to the gestational age at delivery
(<32th weeks of gestation; from 32th to 36th weeks of
gestation; >36th weeks of gestation).
The tests were made with the same frequency in all
cases.
Among 28 + 0 to 32 + 0 weeks of gestation, elective
cesarean section was performed in case of absent end-
diastolic ﬂow in the UA or DV PI >95th centile
and/or cCTG abnormalities (low short-term variability
or recurrent deceleration). After 32 + 1 weeks of
gestation elective cesarean section was performed in
the case of PI >95th centile in the UA or PI <5th
centile in the middle cerebral artery and/or cCTG
abnormalities (e.g. low short-term variability).
For most patients, the delivery occurred after at
least 24 h the administration of maternal steroids
before 34 weeks.
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Signal acquisition
The antepartum cCTG monitoring was performed in
a controlled clinical environment with the patient
lying on an armchair. cCTG records were obtained
using Corometrics 170, General Electrics. The
cardiotocograph is equipped with two transducers:
the ﬁrst one is an ultrasound transducer to detect the
FHR, posted next to the focus of maximum ausculta-
tion of fetal heart; the second one is a pressure trans-
ducer for uterine contractile activity located next to
the uterine fundus.
The cardiotocograph is connected to a smartphone
that, via general packet radio service, sends traces to
the operation center, interfaced to 2CTG2 system
(SEA) for computerized analysis on segments 3 min
long of recording.
The FHR records were performed according to the
American College of Obstetrician and Gynecologists
guidelines and the FHR analysis was carried out
using segments of 3 min (360 data points) without
missing data, in order to prevent inﬂuences of incor-
rect heart rates and to obtain the same length of anal-
ysis segment for all parameters investigated,
irrespective of the traces length. The initial, the mid-
dle and the ﬁnal 3 min of each trace were averaged,
in order to obtain a single analysis segment for each
trace.
The hewlett packard (HP) fetal monitors use an
autocorrelation technique to compare the
demodulated Doppler signal of a heartbeat with the
next one. Each Doppler signal is sampled at 200 Hz
(5 ms). The time window over which the autocorrela-
tion function is computed is 1.2 s, corresponding to
an FHR lower bound of 50 bpm. A peak detection
software then determines the heart period (the equiv-
alent of RR period) from the autocorrelation function.
With a peak position interpolation algorithm, the
effective resolution is better than 2 ms.
The HP monitor produces an FHR value in bpm
every 250 ms. In the commercially available system,
the PC reads 10 consecutive values from the monitor
every 2.5 s and determines the actual FHR as the
average of the 10 values (corresponding to an equiva-
lent sampling frequency of 0.4 Hz). We used a modi-
ﬁed 2CTG2 software, which averages two consecutive
values in order to read the FHR values each 0.5 s
(2 Hz). The choice of reading the FHR values each
0.5 s represents a reasonable compromise to achieve
an enough large bandwidth (Nyquist frequency of
1 Hz) and an acceptable accuracy of the FHR signal.
The following cCTG parameters were examined:
fetal heart rate baseline (FHR), short-term variability
(STV), long-term irregularity (LTI), delta, interval
index (II), approximate entropy (ApEn), high fre-
quency (HF), low frequency (LF), movement fre-
quency (MF), LF/ (HF + MF) ratio (LF/(HF + MF))
and number of decelerations.
Baseline. It is a running average of the heart rate
where accelerations and decelerations are deﬁned as
deviations of the FHR from the baseline lasting a suf-
ﬁcient amount of time. In an automated system for
the evaluation of the CTG recordings, a reproducible
determination of the baseline is fundamental. We
used a real-time version of Mantel’s algorithm.15
Short-term variability: STV quantiﬁes FHR variability
over a very short time scale on a beat-to-beat basis.
Considering 1 min of interbeat sequence, T24(i) in ms,
i = 1, …, 24, we deﬁned STV as:
STV=mean T24 i+ 1ð Þ−T24 ið Þj j½ i =
Σ23i=1 T24 i+ 1ð Þ−T24 ið Þj j
23
where T24(i) is the value of the signal ?(i) taken each
2.5 s. The differences in these 24 values per minute
are calculated and their absolute values were
averaged.16
Long-term irregularity: LTI is computed on a 3-min
segment of interbeat sequence in milliseconds. Given
a signal? 24(i) with i 2 [1; 72], LTI is deﬁned as the
interquartile range (1/4; 3/4) of the distribution of the
modal m24(j) with i 2 [1; 71]16:
m24 jð Þ=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
T242 jð Þ+T242 j+ 1ð Þ
q
Approximate entropy: ApEn is a collection of statisti-
cal indexes. It measures the regularity and, indirectly,
the correlation and the persistence of a signal: small
values indicate reduced signal irregularity. We use
the original deﬁnition by Pincus17:
ApEn_ m,rð Þ= Σ
N−m+ 1
i=1 logCi m,rð Þ
N−m+ 1
−
ΣN−mi= 1 logCi m+ 1,rð Þ
N−m
where m is a natural number, r is a positive real and
N = 720. The parameter m determines the lengths of
the vectors that are compared. By increasing m it
increases the degree of detail for the signal analysis.
The r parameter represents the ﬁltering level or, in
other words, the tolerance level with respect to signal
outliers: differences between two vectors smaller than
r, in absolute value, are considered not relevant.18
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Delta: Given a minute of signal in millisecond T24(i)
with i 2 [1; 24], Delta is deﬁned as the difference
between the maximum and minimum FHR values
and represents medium term variability:
Delta = maxT24 ið Þ – minT24 ið Þ
Arduini et al.16 excluded big accelerations and
decelerations from the calculation.
Interval index: II is calculated as the coefﬁcient of
variation between the differences of all FHR values in
1 min of interbeat sequence, taken each 2.5 s. It was
proposed by Yeh et al.19 as a long-term variability sta-
tistic. We adopted the formulation used by Arduini
et al.16:
II =
std T24 i+ 1ð Þ−T24 ið Þ½ 
STV
, i= 1,…,23
Power spectral analysis of FHR variability: The Power
Spectrum of FHR variability can be quantiﬁed during
the period of activity and fetal sleep by the use of
mathematical algorithms in the following frequency
ranges: low frequency (LF: 0.03–0.15 Hz), movement
frequency (MF: 0.15–0.50 Hz, not present in adult
human subjects) and high frequency (HF:
0.50–1.00 Hz) ranges, generally. LF and HF bands are
associated with the autonomic nervous system (ANS)
activity (mainly sympathetic and parasympathetic
branches, respectively) while the MF band is con-
nected to fetal movements and maternal respiratory
frequency. The LF/(HF + MF) ratio was also
estimated as well and it quantiﬁes the autonomic bal-
ance between neural control mechanisms from differ-
ent origin (in accordance with the LF/HF ratio
normally calculated in adults). For a detailed descrip-
tion of how these parameters are computed, please
refer to Reference 13
Statistical analyses
Data statistical analysis was performed using statis-
tical package for social science (SPSS) version 19.0
software for windows statistical package. The
Kolmogorov–Smirnov test showed a Gaussian dis-
tribution in both populations for all parameters
investigated. Analysis of variance (ANOVA) test
investigated the existence of a statistical signiﬁcant
difference between Healthy and IUGR fetuses and
among the three subgroups of IUGR.
Results
In a period of 3 years we evaluated 430 singleton
pregnancies, composed of 200 Healthy and 230 IUGR
fetuses. IUGR group was composed of 72 fetuses
below the 32th week of gestation, 112 fetuses between
the 32th and 36th week of gestation, and 46 fetuses
over the 36th week of gestation.
The 20.5% of the IUGR fetuses were transferred to
neonatal intensive care (TIN) at birth and neonatal
mortality occurred in 8.4% of cases before 32th weeks.
Fetal pH at birth was in the range of normality for all
subgroups (Table 1), we excluded 26 IUGR and
Table 1 Maternal and perinatal characteristics
Healthy IUGR
<32 weeks 32–36 weeks >36 weeks <32 weeks 32–36 weeks >36 weeks
Demographic data
Patients (n) 20 80 100 72 112 46
Maternal age (years)† 34  3.9 33  5.8 32.09  4.9 32.8  5.4 32.2  5.7 32.6  6.6
Week of delivery† 30.7  0.9 35.5  2.5 39.3  1.1 29.5  1.7 34.8  1.4 37.5  3.9
Cesarean section (%) 25 50 39 98.5 94.3 47.8
Vaginal delivery (%) 75 50 61 1.5 5.6 52.2
Neonatal data
Birth weight (g)† 1646  158 2651  669 3311  372 939  311 1698  365 2186  423
Female (%) 40 50 45 25 49.1 56.4
Apgar <7 at 1 min (%) 10 2.5 1 61.1 9.8 10.8
Apgar <7 at 5 min (%) 0 0 0 12.5 3.6 0
pH† 7.31  0.03 7.30  0.04 7.28  0.08 7.25  0.1 7.31  0.5 7.30  0.07
pCO2
† 38  2.9 44.67  4.94 45.8  9.7 47.22  14.1 48.44  8.8 48.8  10.5
pO2
† 18  4.08 21.11  16.2 19.7  8.3 7.77  9.2 7.11  5.4 16.5  13.2
Base Excess† −2  2.9 −2  3.23 −4.4  3.3 −1.6  4.6 −1.5  3.1 −1.9  3.6
Neonatal mortality (%) 0 0 0 8.4 0 0
†Values above are expressed as mean  standard deviation.
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39 Healthy for inadequate umbilical cord samples at
birth for both pH and gas values (insufﬁcient blood
sampling and/or errors in pH and gas analysis by the
pH meter).
The ANOVA test revealed a signiﬁcant difference
for birth weight, week of delivery, Apgar Score at
1 min, pO2 and pCO2 between each subgroup of
study compared to each one of the other group (P <
0.05), as they were preselected for the differences. In
the 32–36th weeks subgroup, the ANOVA test also
showed a statistically signiﬁcant difference for Apgar
at 5 min, while no difference was observed between
‘<32 weeks versus 32–36 weeks’ in IUGR for pO2.
(P < 0.05).
Table 2 Results of comparison between Healthy and IUGR fetuses
Healthy (mean  SD) IUGR (mean  SD) P-value*
FHR (bpm)
<32th 143.06  8.63 143.49  7.52 0.91
32th–36th 135.6  10.34 138.8  9.64 0.22
>36th 137.19  8.11 134.38  10.2 <0.05**
STV (ms)
<32th 5.34  1.88 3.11  1.31 <0.01
32th–36th 6.67  1.89 5.11  2.30 <0.05
>36th 6.39  1.87 6.13  1.88 0.36
LTI (ms)
<32th 19.70  4.07 14.51  5.77 0.08
32th–36th 21.51  6.29 18.49  6.03 0.06
>36th 21.70  5.94 21.33  5.53 0.68
ApEn
<32th 1.22  0.17 1.24  0.23 0.08
32th–36th 1.28  0.16 1.33  0.18 0.06
>36th 1.31  0.16 1.28  0.19 0.68
Delta (ms)
<32th 35.85  9.54 24.82  10.13 <0.05
32th–36th 41.8  9.43 33.22  11.65 <0.05
>36th 41.12  10.04 39.25  8.75 0.21
II
<32th 0.83  0.01 0.87  0.06 0.19
32th–36th 0.85  0.08 0.84  0.06 0.44
>36th 0.85  0.05 0.83  0.05 <0.05
LF (ms2)
<32th 84.63  4.85 79.74  6.83 0.16
32th–36th 82.33  5.20 81.10  5.84 0.43
>36th 81.66  5.41 80.98  12.13 0.56
MF (ms2)
<32th 9.35  1.62 12.20  3.45 0.10
32th–36th 11.91  3.55 13.15  9.09 0.59
>36th 12.93  3.42 11.18  3.44 0.001
HF (ms2)
<32th 6.02  4.54 8.01  4.70 0.41
32th–36th 8.00  9.27 6.86  4.72 0.43
>36th 5.41  3.17 6.06  3.68 0.20
LF/(HF + MF)
<32th 5.17  3.24 3.99  2.47 0.36
32th–36th 3.51  1.95 4.20  1.99 0.19
>36th 4.13  2.07 3.91  2.38 0.5
Deceleration (n)
<32th 0.00  0.00 0.78  1.55 0.32
32th–36th 0.00  0.00 0.43  0.87 0.05
>36th 0.07  0.26 0.35  0.75 <0.001
*P-value for comparison between Healthy and IUGR; **Values in bold are statistically signiﬁcant. ApEn, approximate entropy; FHR, fetal
heart rate; HF, high frequency; II, interval index; IUGR, intrauterine growth restriction; LF, low frequency; LF/(HF + MF), the
LF/(HF + MF) ratio; LTI, long-term irregularity; MF, movement frequency; SD, standard deviation; STV, short-term variability.
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Finally, in the subgroup >36th week, a statistically
signiﬁcant difference was also observed for the Base
Excess (P < 0.05). No differences were found with
respect to the gender of newborns.
The aim of the study was to identify which parame-
ter or parameters set is most efﬁcient in the discrimi-
nation between Healthy and IUGR fetuses. The
ANOVA test showed statistically signiﬁcant differ-
ences between Healthy and IUGR in the <32th week
subgroup for STV and Delta. In the comparison
between Healthy and IUGR in the 32–36th subgroup
a statistically signiﬁcant difference is observed for
STV, Delta and the number of decelerations, while in
the >36th subgroup, the ANOVA test showed statisti-
cally signiﬁcant differences for FHR, II, MF and the
number of decelerations (Table 2).
A comparison study between early- and late-onset
IUGR was made to highlight any difference among
cCTG parameters. The ANOVA test showed a statisti-
cally signiﬁcant difference between the three IUGR
subgroups for the following parameters: FHR, STV,
LTI, II, Delta, ApEn, HF and number of decelerations
(Table 3).
Among the IUGR subgroups, the ANOVA test with
Bonferroni correction evidenced a statistically signiﬁ-
cant difference between each subgroup of the study
compared to each one of the other two (‘<32th week’
vs ‘32–36th week’; ‘<32th week’ vs ‘>36th week’; and
‘32–36th week’ vs ‘>36th week’ groups) for FHR, STV,
LTI, Delta (P < 0.05). A statistically signiﬁcant differ-
ence was found between ‘<32th week’ and ‘32–36th
week’, ‘<32th week’ and ‘>36th week’ for II and
between ‘<32th week’ versus ‘32–36th week’ for ApEn
in IUGR subgroups. No statistically signiﬁcant differ-
ences were found for spectral analysis parameters.
We evaluated the correlation between fetal pH
values at birth and STV values in Healthy and IUGR
fetuses delivered by cesarean section, in order to
avoid the effect of labor on fetal pH at birth. Receiver
operating characteristic (ROC) curves have not shown
a correlation between STV and pH values in IUGR
(area = 0.371; P = 0.076) and in Healthy group
(area = 0.516; P = 0.084) (Fig. 1).
Discussion
Aim of this study was to investigate the car-
diotocographic characteristics of IUGR fetuses and to
identify every cCTG differences between Healthy and
IUGR fetuses. In order to improve clinical manage-
ment, we decided to separate IUGR fetuses into three
subgroups, according to different pathophysiology
between early- and late-onset IUGR. In fact, the early
onset is associated with severe placental insufﬁciency
and Doppler abnormalities, while the late onset is fre-
quently associated with mild placental insufﬁciency
and normal Doppler velocimetry.8,20
The STV is the most signiﬁcant indicator of fetal
homeostasis, especially when it is compared to long
and medium term variability. In fact, STV is the most
extensively studied parameter of cCTG, because it is
able to assess the baroreﬂex and the integrity of the
ANS and its connections with the CNS11,12: normal









FHR (bpm) 143.49  7.52 138.8  9.64 134.38  10.26 <0.0001*,***; 0.003A–B**; <0.0001A–C; 0.013B–C
STV (ms) 3.11  1.31 5.11  2.30 6.13  1.88 <0.0001; <0.0001A–B; <0.0001A–C; 0.006B–C
LTI (ms) 14.51  5.77 18.49  6.03 21.33  5.53 <0.0001; <0.0001A–B; <0.0001A–C; 0.011B–C
ApEn 1.24  0.23 1.33  0.18 1.28  0.19 <0.05; 0.016A–B; 0.968A–C; 0.375B–C
Delta (ms) 24.82  10.13 33.22  11.65 39.25  8.75 <0.0001; <0.0001A–B; <0.0001A–C; 0.002B–C
II 0.87  0.06 0.84  0.06 0.83  0.05 <0.0001; 0.001A–B; <0.0001A–C; 0.825B–C
LF (ms2) 79.74  6.83 81.10  5.84 80.98  12.13 0.52; 0.824A–B; 1.000A–C; 1.000B–C
MF (ms2) 12.20  3.45 13.15  9.09 11.18  3.44 0.20; 1.000A–B; 1.000A–C; 0.230B–C
HF (ms2) 8.01  4.70 6.86  4.72 6.06  3.68 0.05; 0.297A–B; 0.051A–C; 0.859B–C
LF/(HF + MF) 3.99  2.47 4.20  1.99 3.91  2.38 0.70; 1.000A–B; 1.000A–C; 1.000B–C
Deceleration (n) 0.78  1.55 0.43  0.87 0.35  0.75 0.05; 0.124A–B; 0.086A–C; 1.000B–C
*P-value for comparison of the three groups using the ANOVA test; **P-value for comparison of the three groups using the ANOVA test
with the Bonferroni correction A–B (<32 weeks vs 32–36 weeks), A–C (<32 weeks vs >36 weeks), B–C (32–36 weeks vs >36 weeks) groups;
***Values in bold are statistically signiﬁcant. ApEn, approximate entropy; FHR, fetal heart rate; HF, high frequency; II, interval index;
IUGR, intrauterine growth restriction; LF, low frequency; LF/(HF + MF), the LF/(HF + MF) ratio; LTI, long-term irregularity; MF, move-
ment frequency; SD, standard deviation; STV, short-term variability.
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STV values reﬂect an healthy ANS, normal activity of
chemoreceptors, baroreceptors and cardiac respon-
siveness, while low STV values are associated with
impending deterioration of fetal oxygen supply and
therefore fetal distress.21,22
In the clinical practice, abnormal low STV values
reﬂect acute changes in the fetal condition and they
are associated with an increased risk of motor and
neurological delay in preterm IUGR and damage in
speciﬁc brain areas with cognitive effects as gestation
advances.23
It is reported that in IUGR fetuses there is a delay
in the stages of biophysical development, which may
be related to chronic hypoxia.24 This delay affects the
ANS maturation.
Our results are expression of different
etiopathogenesis between early- and late-onset IUGR;
in fact, in early-moderate IUGR, a statistically sig-
niﬁcant difference is evident in the parameters of
short- and medium-term variability (STV and Delta)
compared to healthy ones of the same gestational age.
This difference could be a manifestation of the effect
of chronic hypoxia on the development and function-
ing of the autonomous fetal nervous system (SNA). In
the late-onset IUGRs, this difference is not meaning-
ful, probably because of mild-moderate uterus-
placental insufﬁciency which determines a minor
impact on neurodevelopment; in our study only FHR
and MF are statistically different between late-onset
IUGR and Healthy subgroups.
Movement frequency quantiﬁes fetal movements,
basically of the trunk. It also depends on maternal
breathing, as an high correlation between the fetal MF
component and the maternal respiratory frequency
was found. Lower MF values in IUGR fetuses reﬂect
a minor reactivity and responsiveness to external and
internal stimuli, expression of lower energy and/or
oxygen reserves of these fetuses than the healthy
fetuses.25
In our study, the FHR values were found to be
lower in late-onset IUGR subgroup than in Healthy
ones; this result is in disagreement with the evidence
that IUGR causes a delay in the maturation of the
parasympathetic branch of the ANS with a compensa-
tory activity of the sympathetic branch. However,
some studies, showed lower FHR in late-onset IUGR
than in Healthy at the same gestational age, and higher
FHR in early-onset IUGR than Healthy at the same
gestational age. It has been suggested that the sympa-
thetic nervous system is more affected than parasym-
pathetic tone in IUGR. Therefore, the prevalence of the
parasympathetic tone could justify the ﬁnding of a
lower baseline at certain gestational ages.24,26,27
According to Baschat,21 the longitudinal progression
of abnormal Doppler waveforms in the early IUGR
deterioration of uteroplacental function is the following:
elevated umbilical artery blood ﬂow resistance and
reduced umbilical vein ﬂow volume precede the onset
of a growth delay, followed by decreased middle cere-
bral artery impedance and increased brain venous blood
ﬂow velocities which characterize the ‘brain sparing
effect’. These early responses are physiologically
followed by late-onset Doppler abnormalities such as
absent/reversed umbilical artery end-diastolic velocity,
absent/reversed ductus venosus waves. Instead in late-
onset IUGR there is not always evidence of this
Figure 1 ROC curves between STV and pH values at birth in IUGR and Healthy fetuses, respectively. ROC, receiver oper-
ating characteristic; IUGR, intrauterine growth restriction; STV, short-term variability.
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progression because the umbilical artery and the ductus
venosus are almost always regular, while the middle
cerebral artery can occasionally shows a reduced PI.
In the context of IUGR fetuses, statistically signiﬁ-
cant differences were found on the basis of gestational
age. FHR baseline shows a progressive reduction as
the gestational age increases, it could be the conse-
quence of the progressive maturation of the parasym-
pathetic branch of the ANS.
Short-, medium- and long-term variability values
were different for all pairwise comparisons between
IUGR subgroups, showing lower values in the early-
onset IUGR with respect to the late-onset ones.
These results could be related to progressive matu-
ration of the ANS but they also could be inﬂuenced
by different degree of involvement of the SNA at the
hypoxic insult: as soon as the insult occurs, the dam-
age and the onset of an alteration of the biophysical
parameters will be more serious.
According to our previous study,28 chronic hypox-
emia is responsible for a delay in the maturation of all
the components of the ANS and their integration with
the CNS. This delay causes lower values of short- and
long-term variability.
In addition, chronic hypoxemia is associated with
normal pH values at birth, while low pH values
mainly correlate with progression to metabolic and
respiratory acidosis. According to literature, our study
shows a weak no correlation between STV values and
pH at birth in IUGR and Healthy groups. This corre-
lation is probably caused by three outliers with low
STV and pH values. In fact, Kapaya et al. showed
moderate accuracy of STV in predicting fetal
acidemia; also Pels et al. did not support an associa-
tion of STV and short- or long-term outcome.29,30
Studies evaluating the monitoring of pregnancies
complicated by IUGR are very heterogeneous and its
pathophysiology is constantly evolving. As a result, to
date no shared global guidelines on IUGR monitoring
are available and the timing of delivery a preterm
IUGR fetus remains one of the major challenges in
obstetrics. Cardiotocography is a useful tool for the
evaluation of these fetuses, but requires integration
with fetal ultrasound and Doppler vessels evaluation
to improve the ability to predict the neonatal outcome.
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